Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Cardiol. Jun 26, 2025; 17(6): 106717
Published online Jun 26, 2025. doi: 10.4330/wjc.v17.i6.106717
Table 4 Echocardiographic parameters of the included patients
Variable
Transient improvement (n = 39)
Sustained improvement (n = 136)
P value
Baseline (Echo-1)
LVEF (%)30.56 ± 6.9526.77 ± 7.050.003
Average E/e’15.01 ± 5.88 (n = 20)14.52 ± 5.78 (n = 67)0.74
LA volume index (mL/m2)35.97 ± 12.51 (n = 25)37.09 ± 11.35 (n = 82)0.68
LVEDD (cm)5.76 ± 0.79 (n = 37)6.70 ± 4.17 (n = 130)0.18
LVESD (cm)4.76 ± 0.84 (n = 34)5.08 ± 0.89 (n = 115)0.80
RVSP (mmHg)33.46 ± 11.06 37.35 ± 12.89 (n = 130)0.13
Second follow-up (Echo-3)
LVEF (%)28.46 ± 6.5940.18 ± 0.120.001
Average E/e’13.12 ± 5.46 (n = 19)12.08 ± 5.86 (n = 77)0.49
LA volume index (mL/m2)41.41 ± 12.92 (n = 31)34.30 ± 11.26 (n = 114)0.003
LVEDD (cm)6.06 ± 0.62 (n = 38)5.81 ± 0.89 (n = 134)0.05
LVESD (cm)4.99 ± 0.75 (n = 37)4.50 ± 0.95 (n = 131)0.004
RVSP (mmHg)38.78 ± 14.61 (n = 37)33.10 ± 11.82 (n = 129)0.04
LVEF (Echo-2)38.59 ± 7.5736.33 ± 7.690.11
∆ LVEF (Echo-2 - Echo-1) (%)8.05 ± 6.539.54 ± 7.690.27
Duration between Echo-1 and Echo-2 (months)19.82 ± 26.6117.24 ± 21.150.53
∆ LVEF (Echo-3 - Echo-1) (%)-2.10 ± 5.0513.43 ± 9.090.001
Duration between Echo-2 and Echo-3 (months)20.49 ± 13.4021.79 ± 23.390.74